Carl Zeiss Meditec AG (ETR:AFX)
Germany flag Germany · Delayed Price · Currency is EUR
32.30
-0.18 (-0.55%)
Aug 24, 2026, 5:35 PM CET

Carl Zeiss Meditec AG Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Carl Zeiss Meditec AG stock has a consensus rating of "Hold" and an average price target of €27.24. The average 1-year stock price forecast is 15.67% lower than the current stock price, while the lowest is €18.10 (-43.96%) and the highest is €35.00 (+8.36%).

Price Target: €27.24 (-15.67%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price€18.10€27.24€27.00€35.00
Change-43.96%-15.67%-16.41%+8.36%

Analyst Ratings

The average analyst rating for Carl Zeiss Meditec AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy111110
Buy110000
Hold131314141311
Sell111111
Strong Sell000003
Total161616161515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Berenberg Bank
Berenberg Bank
Hold
Maintains
€28.00
HoldMaintains€28.00-13.31%Aug 19, 2026
Unknown Analyst
DZ BANK AG
No rating
DZ BANK AG
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 14, 2026
Deutsche Bank
Deutsche Bank
Hold
Maintains
€28.00€26.00
HoldMaintains€28.00€26.00-19.50%Aug 12, 2026
UBS
UBS
Sell
Downgrades
€25.00€22.60
SellDowngrades€25.00€22.60-30.03%Aug 11, 2026
Barclays
Barclays
Hold
Maintains
€28.00€27.00
HoldMaintains€28.00€27.00-16.41%Aug 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.18B
from 2.23B
Decreased by -2.19%
Revenue Next Year
2.29B
from 2.18B
Increased by 4.88%
EPS This Year
1.35
EPS Next Year
1.55
from 1.35
Increased by 15.17%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
1.65B1.90B2.09B2.07B2.23B2.18B
Revenue Growth
23.31%15.55%9.80%-1.11%7.82%-2.19%
Gross Profit
967.21M1.13B1.21B1.09B1.18B1.11B
Gross Margin
58.73%59.26%57.71%52.69%52.76%50.91%
Operating Income
370.38M397.68M349.06M177.21M223.30M153.28M
Net Income
236.28M293.91M290.40M178.73M141.21M54.74M
EPS
-----1.35
Forward PE
57.1434.3025.6627.9920.7723.94
Dividend / Share
0.901.101.100.600.550.47
Dividend Growth
80.00%22.22%--45.46%-8.33%-14.28%
Free Cash Flow
59.29M132.07M73.93M783.80M87.32M59.02M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High2.2B
Avg2.2B
Low2.1B

Revenue Growth

Revenue Growth202620272028
High
0.2%
Avg
-2.2%
Low
-3.8%

EPS Forecast

EPS202620272028
High1.63
Avg1.35
Low1.00

EPS Growth

EPS Growth202620272028
High
-29.5%
Avg
-41.8%
Low
-56.8%